Article Review: IC application for duodenum ulcer complex therapy

Anton Sheikh-Fedorenko
January 30, 2018
The article titled "Technologies that Challenge Current Thinking: transfer of properties of medical drugs via lines of communication" written by Khachumova, K.G., Surinov, B.P., Voeikov, V.L., Germanov, E.P., and Fedorenko, A.A. discusses infoceuticals and one part of the paper looked at duodenum ulcer therapy. Below we have summarized the author's findings from the duodenum ulcer study. The original article is written in Russian and can be found at: Хачумова К.Г., Суринов Б.П., Воейков В.Л., Германов Е.П., Федоренко А.А. (2014). Технологии, которые делают вызов современному мышлению: передача свойств лекарственных препаратов по линиям связи. International Journal of Unconventional Science. http://www.unconv-science.org/pdf/5/khachumova-ru.pdf


60 women (age of 30,5±4,8 years old) diagnosed with duodenum ulcers were examined in the acute stage. Ulcer diameter was in the range of 7.6±0.7 mm. 80% of the patients had single ulcers, 20% had multiple ones. Patients had symptoms for less than 1 year. 

Depending on prescribed therapy, patients were divided into 3 groups (Table 1).

Table 1. Groups of patients and prescribed therapy
 

Esophagogastroduodenoscopy (EGDS) was prescribed for all the patients in the beginning, and repeated after 14 days and 28 days. After 6-8 months, EGDS was prescribed for 14 patients from the 1st group, 20 patients from the 2nd group, and 20 patients from the 3rd group. The dynamics of the clinical symptoms of the patients were also examined – abdominal pain, heartburn, eructation, nausea, and vomiting. 

 Presented data demonstrate that duodenal ulcers scarring process occurred significantly faster in the second group of patients, who accepted medical drugs together with the consumption of the set of ICs, compared to the patients in the first group, and a bit quicker, compared to the patients in the 3rd group (Fig.1). Reduction of almost all basic clinical symptoms was notably the quickest for the patients in the second group, compared to the 1st and the 3rd ones (Fig.2); efficiency of Helicobacter Pylori eradication after 2 weeks of therapy is similar for the 1st and for the 2nd groups, but it is essentially higher (almost 3 times), than for the patients in the 3rd group (Fig. 3).   

Figure 1. Duodenal ulcers scarring rate dynamics, %


Figure 2. Terms of basic clinical symptoms reduction in different groups of patients, days

Figure 3. Helicobacter Pylori eradication efficiency after 2 weeks, %


Examination after 6-8 months confirmed that the patients in the 2nd group had the lowest Helicobacter Pylori seeding (Fig. 4). 

Figure 4. Absence of seeding of Helicobacter pylori after 6-8 months,%



The presented results related to duodenal ulcer treatment, agree with the literature data for the 1st and for the 3rd groups [ref:1-3]. By including a set of ICs in drinking water together with Omeprazol allowed for notably better results in the treatment of duodenal ulcer, compared to the standard complex treatment of this disease with a set of medical drugs or with Omepazol alone.

 

7
5307